Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP844883.RAA76CtKHrAYKCToqI15sivibHRgDjTT07AyGPIIowbSU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP844883.RAA76CtKHrAYKCToqI15sivibHRgDjTT07AyGPIIowbSU130_assertion type Assertion NP844883.RAA76CtKHrAYKCToqI15sivibHRgDjTT07AyGPIIowbSU130_head.
- NP844883.RAA76CtKHrAYKCToqI15sivibHRgDjTT07AyGPIIowbSU130_assertion description "[We have previously shown that glucose-dependent insulinotropic polypeptide (GIP) analogues that originally have been developed to treat diabetes have neuroprotective effects in the brains of the APPswe/PS1?E9 mouse model of AD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP844883.RAA76CtKHrAYKCToqI15sivibHRgDjTT07AyGPIIowbSU130_provenance.
- NP844883.RAA76CtKHrAYKCToqI15sivibHRgDjTT07AyGPIIowbSU130_assertion evidence source_evidence_literature NP844883.RAA76CtKHrAYKCToqI15sivibHRgDjTT07AyGPIIowbSU130_provenance.
- NP844883.RAA76CtKHrAYKCToqI15sivibHRgDjTT07AyGPIIowbSU130_assertion SIO_000772 23568101 NP844883.RAA76CtKHrAYKCToqI15sivibHRgDjTT07AyGPIIowbSU130_provenance.
- NP844883.RAA76CtKHrAYKCToqI15sivibHRgDjTT07AyGPIIowbSU130_assertion wasDerivedFrom befree-20140225 NP844883.RAA76CtKHrAYKCToqI15sivibHRgDjTT07AyGPIIowbSU130_provenance.
- NP844883.RAA76CtKHrAYKCToqI15sivibHRgDjTT07AyGPIIowbSU130_assertion wasGeneratedBy ECO_0000203 NP844883.RAA76CtKHrAYKCToqI15sivibHRgDjTT07AyGPIIowbSU130_provenance.